Pyc Therapeutics Limited has released a press release.
S&P DJI Announces September 2026 Quarterly Rebalance
Earlier from Pyc Therapeutics
- PKD - Safety Committee Approves Dose Escalation
- ADOA Program Update
- PKD - Initiation of Multiple Dose Clinical Trial
- Presentation of Ophthalmology Clinical Trial Data at ARVO